Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amicus Therapeutics (FOLD) Inventory Average (2016 - 2025)

Amicus Therapeutics' Inventory Average history spans 10 years, with the latest figure at $203.4 million for Q4 2025.

  • For the quarter ending Q4 2025, Inventory Average rose 73.73% year-over-year to $203.4 million, compared with a TTM value of $203.4 million through Dec 2025, up 73.73%, and an annual FY2025 reading of $173.8 million, up 94.76% over the prior year.
  • Inventory Average for Q4 2025 was $203.4 million at Amicus Therapeutics, up from $166.4 million in the prior quarter.
  • The five-year high for Inventory Average was $203.4 million in Q4 2025, with the low at $17.1 million in Q3 2022.
  • Average Inventory Average over 5 years is $66.7 million, with a median of $46.7 million recorded in 2023.
  • Year-over-year, Inventory Average decreased 26.01% in 2022 and then surged 217.17% in 2023.
  • Tracing FOLD's Inventory Average over 5 years: stood at $24.4 million in 2021, then decreased by 24.14% to $18.5 million in 2022, then surged by 214.47% to $58.3 million in 2023, then skyrocketed by 100.73% to $117.1 million in 2024, then surged by 73.73% to $203.4 million in 2025.
  • Per Business Quant, the three most recent readings for FOLD's Inventory Average are $203.4 million (Q4 2025), $166.4 million (Q3 2025), and $143.6 million (Q2 2025).